A Comparative Study on the Viability of Normal and Cancerous Cells upon Irradiation with a Steady Beam of THz Rays.
apoptosis
blood cells
cancer cells
cell death
terahertz (THz) irradiation
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
05 Mar 2022
05 Mar 2022
Historique:
received:
21
02
2022
accepted:
01
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Terahertz (THz) electromagnetic radiation is commonly used in astronomy, security screening, imaging, and biomedicine, among other applications. Such approach has raised the question of the influence of THz irradiation on biological objects, especially the human body. However, the results obtained to date are quite controversial. Therefore, we performed a comparative study on the viability of normal cells and cancer cells upon irradiation with a steady beam of THz rays. We used human peripheral blood mononuclear cells and cancer cell lines. Primary human mononuclear blood cells (monocytes, and B-, and T-cells) showed an increased death rate, determined by cell counting and fluorescence microscopy, upon 0.14 THz irradiation. The effect of THz radiation was different among malignant cells of B- and T-cell origin (Ramos and Jurkat cells) and epithelial cancer cells (MCF7 and LNCaP). This was demonstrated by cell counting and by the alamarBlue assay. In conclusion, THz radiation can result in the death of human primary and malignant cells. However, the mechanism of this phenomenon is largely unknown. Hence, more work should be done to shed some light on the mechanism of action of THz irradiation in living organisms to enhance technologic developments.
Identifiants
pubmed: 35330127
pii: life12030376
doi: 10.3390/life12030376
pmc: PMC8951499
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Sci Rep. 2020 Jun 2;10(1):9008
pubmed: 32488073
EMBO J. 1991 Oct;10(10):2879-87
pubmed: 1915267
Biomed Opt Express. 2021 Jun 01;12(6):3729-3742
pubmed: 34221691
Sci Rep. 2015 Jan 13;5:7749
pubmed: 25582954
J Pharmacol Toxicol Methods. 2014 Sep-Oct;70(2):195-8
pubmed: 24933394
Radiat Res. 2013 Jan;179(1):38-45
pubmed: 23181591
PLoS One. 2010 Dec 31;5(12):e15806
pubmed: 21209821
Biomed Opt Express. 2011 Sep 1;2(9):2679-89
pubmed: 21991556
Radiat Res. 2008 Aug;170(2):224-34
pubmed: 18666810
Proc Natl Acad Sci U S A. 2011 May 24;108(21):8663-7
pubmed: 21555580
Mutat Res Genet Toxicol Environ Mutagen. 2015 Nov;793:150-60
pubmed: 26520385
Sci Rep. 2013;3:1184
pubmed: 23378916
Biophys J. 2021 Jun 15;120(12):2386-2393
pubmed: 33894216
Sci Rep. 2018 Jul 3;8(1):9990
pubmed: 29968762
Sci Rep. 2021 Sep 9;11(1):17916
pubmed: 34504144
Prostate. 2003 Nov 1;57(3):205-25
pubmed: 14518029
Biomed Opt Express. 2021 Oct 26;12(11):7122-7138
pubmed: 34858704
PLoS One. 2021 Aug 2;16(8):e0248381
pubmed: 34339441
Biomed Opt Express. 2013 Apr 1;4(4):559-68
pubmed: 23577291
Opt Express. 2014 May 19;22(10):11465-75
pubmed: 24921268
Environ Mol Mutagen. 2018 Jul;59(6):476-487
pubmed: 29602275
Cancers (Basel). 2019 Jan 31;11(2):
pubmed: 30709066
Phys Med Biol. 2013 Jan 21;58(2):373-91
pubmed: 23257566
Opt Express. 2018 Sep 3;26(18):22709-22721
pubmed: 30184927